Achieve Life Sciences, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Achieve Life Sciences, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $273.00K.
- Achieve Life Sciences, Inc. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $26.00K, a 13.04% increase year-over-year.
- Achieve Life Sciences, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $18.00K.
- Achieve Life Sciences, Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $23.00K.
- Achieve Life Sciences, Inc. stock issued during period, value, new issues for fiscal 2023 was $273.00K, a 950.00% increase from fiscal 2022.
- Achieve Life Sciences, Inc. stock issued during period, value, new issues for fiscal 2022 was $26.00K, a 36.59% decline from fiscal 2021.
- Achieve Life Sciences, Inc. stock issued during period, value, new issues for fiscal 2021 was $41.00K.
- Achieve Life Sciences, Inc. stock issued during period, value, new issues for fiscal 2014 was $2.86M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $273.00K 10-K · filed 2026-03-24 | |
| 2023-09-30 | $273.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $26.00K 10-K · filed 2025-03-11 | |
| 2022-03-31 | $26.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $41.00K 10-K · filed 2024-03-28 | |
| 2021-06-30 | $18.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $23.00K 10-Q · filed 2022-11-14 | |
| 2014-12-31 | $2.86M 10-K · filed 2015-03-26 | |
| 2012-12-31 | $53.78M 10-K · filed 2014-03-11 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | |
| 2012-03-31 | -$53.78M 10-Q · filed 2013-05-02 | |
| 2011-12-31 | $0.00 10-K · filed 2012-03-08 | |
| 2010-12-31 | -$32.32M 10-K · filed 2013-03-07 | |
| 2009-12-31 | $9.30M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |